Didascalia
: Sperimentazione in fase di reclutamento
= 
; Sperimentazione in corso
= 
-
- FRANCIA
- NORD-PAS-DE-CALAIS
- LILLE
- ANGIO-TAX-PLUS - Phase II study, multicenter, randomized, stratified, evaluating the efficacy of weekly paclitaxel, in association or not with bevacizumab in the treatment of metastatic or locally advanced angiosarcomas not accessible to surgery.
- CRLCC Oscar Lambret
- Département de cancérologie générale
- Ulteriori dettagli
-
- FRANCIA
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first treatment of advanced or metastatic soft tissue sarcoma (Phase III) -Terminated -
- CHU de Marseille - Hôpital de la Timone
- Service d'oncologie médicale
- Ulteriori dettagli
-
- FRANCIA
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- Phase II pharmacokinetic study to assess doxorubicin clearance age-dependency in pediatric patients with solid tumours and leukemia - FR
- CHU de Marseille - Hôpital de la Timone
- Service d'oncologie pédiatrique
- Ulteriori dettagli
-
- ESTIM : Efficacy and safety assessment of oral LBH589 in adult patients with advanced soft tissue sarcoma after doxorubicin failure : an open-label, multi-centric phase II study
- CRLCC Léon Bérard
- Centre Léon Bérard
- Ulteriori dettagli
-
- Multicenter phase I/II study of continuous dosing of Sunitinib in non-GIST sarcomas with concomitant radiation therapy.
- CRLCC Léon Bérard
- Département de radiothérapie
- Ulteriori dettagli
-
- FRANCIA
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- Etude de phase II multicentrique, randomisée et stratifiée comparant l efficacité du Paclitaxel hebdomadaire seul ou en assocation au Bevacizumab dans le traitement des angiosarcomes métastatiques ou localement avancés non accessibles ŕ un traitement chirurgical - FR
- Not yet identified - FR
- Ulteriori dettagli
-
- FRANCIA
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- Multicenter, prospective, open-label, uncontrolled study in patients aged 45 years or older to evaluate the efficacy and safety of Liposomal Doxorubicin (Doxorubicin GP-Pharm) in first-line treatment in soft-tissue sarcomas - FR
- Not yet identified - FR
- Ulteriori dettagli
-
- FRANCIA
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- Phase 1/2 Efficacy, Safety of Plerixafor in Addition to Standard Regimens for Mobilisation of Haematopoietic Stem Cells into Peripheral Blood, and Subsequent Collection by Apheresis, Versus Standard Mobilisation Regimens Alone in Paediatric Patients, with Solid Tumours Eligible for Autologous Transplants - FR
- Not yet identified - FR
- Ulteriori dettagli
-
- FRANCIA
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- An Open-label, Multi-center, Randomized Study of the Safety and Effect on Event-free Survival of Bevacizumab in Combination With Standard Chemotherapy in Childhood and Adolescent Patients With Metastatic Rhabdomyosarcoma and Non-rhabdomyosarcoma Soft Tissue Sarcoma - FR
- Not yet identified - FR
- Ulteriori dettagli
-
- FRANCIA
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- Phase II Study of GW786034 in Patients With Relapsed or Refractory Soft Tissue Sarcoma - FR
- Not yet identified - FR
- Ulteriori dettagli
-
- FRANCIA
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy - FR
- Not yet identified - FR
- Ulteriori dettagli
-
- GERMANIA
- Baden-Württemberg
- STUTTGART
- EURO-B.O.S.S.: A European treatment protocol for bone sarcoma in patients older than 40 years - DE
- Klinikum Stuttgart, Standort Olgahospital
- COSS (Cooperative OsteoSarkom Studiengruppe) Studienzentrale
- Ulteriori dettagli
-
- EORTC 62961: Phase III randomized study of neoadjuvant Etoposide, Ifosfamide, and Doxorubicin with or without regional hyperthermia in patients with high-risk soft tissue sarcoma - Terminated
- LMU Klinikum der Universität München - Campus Großhadern
- Medizinische Klinik und Poliklinik III
- Ulteriori dettagli
-
- GERMANIA
- Niedersachsen
- HANNOVER
- EPAZ: A randomized phase II trial comparing Pazopanib with Doxorubicin as first line treatment in elderly patients with metastatic or advanced Soft Tissue Sarcoma
- Medizinische Hochschule Hannover
- Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
- Ulteriori dettagli
-
- GERMANIA
- Nordrhein-Westfalen
- KÖLN
- EORTC 62072 (PALETTE) - A randomized, double blind phase III trial of Pazopanib versus Placebo in patients with Soft Tissue Sarcoma whose disease has progressed during or following prior therapy - DE
- Universitätsklinikum Köln
- Klinik I für Innere Medizin - AG Prof. Wendtner
- Ulteriori dettagli
-
- GERMANIA
- Nordrhein-Westfalen
- KÖLN
- PICASSO III: A Phase III multicenter, international, randomized, double-blind, placebo-controlled study of Doxorubicin plus Palifosfamide-tris versus Doxorubicin plus Placebo in patients with front-line metastatic Soft Tissue Sarcoma - DE
- Universitätsklinikum Köln
- Klinik I für Innere Medizin - AG Prof. Wendtner
- Ulteriori dettagli
-
- GERMANIA
- Nordrhein-Westfalen
- MÜNSTER
- EPOC-MS-001: Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - DE
- Universitätsklinikum Münster
- AG Prof. Boos: Experimentelle pädiatrische Onkologie
- Ulteriori dettagli
-
- GERMANIA
- Schleswig-Holstein
- KIEL
- A Phase II Trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor for the treatment of patients with recurrent or refractory Ewing's Sarcoma, recurrent or refractory Osteosarcoma, Synovial Sarcoma, Rhabdomyosarcoma and other Sarcomas
- Universitätsklinikum Schleswig-Holstein - Campus Kiel
- Krebszentrum Nord
- Ulteriori dettagli
-
- GERMANIA
- Schleswig-Holstein
- KIEL
- Randomized Phase II Trial of Trofosfamide vs. Adriamycin in elderly patients with previously untreated metastatic Soft Tissue Sarcoma
- Universitätsklinikum Schleswig-Holstein - Campus Kiel
- Krebszentrum Nord
- Ulteriori dettagli
-
- REGNO UNITO; GRAN BRETAGNA
- Greater Manchester
- NOT YET IDENTIFIED - UK
- Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia
- NOT YET IDENTIFIED - UK
- Ulteriori dettagli
-
- REGNO UNITO; GRAN BRETAGNA
- South Yorkshire
- SHEFFIELD
- Axi-STS: A clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas
- Weston Park Hospital
- Cancer Clinical Trials Centre
- Ulteriori dettagli
-
- REGNO UNITO; GRAN BRETAGNA
- South Yorkshire
- SHEFFIELD
- EORTC 62931: Randomized phase III trial of adjuvant chemotherapy with high-dose doxorubicin, ifosfamide and lenograstim in high grade soft tissue sarcoma - UK
- Weston Park Hospital
- Cancer Clinical Trials Centre
- Ulteriori dettagli
-
- REGNO UNITO; GRAN BRETAGNA
- Surrey
- SUTTON
- EORTC 62012: Randomised Trial Of Single Agent Doxorubicin Versus Doxorubicin Plus Ifosfamide In The First Line Treatment Of Advanced Or Metastatic Soft Tissue Sarcoma (Phase III)
- The Royal Marsden Hospital
- Sarcoma Unit
- Ulteriori dettagli
-
- SPAGNA
- Cataluńa
- L'HOSPITALET DE LLOBREGAT
- Phase I-II, Not-Randomized, Multicenter Clinical Trial to Evaluate Safety and Efficacy of Sorafenib (BAY-43-9006) in Combination With Ifosfamide in Soft Tissue Sarcoma
- ICO L'Hospitalet
- Servicio de Oncología Médica (ICO L'Hospitalet)
- Ulteriori dettagli
-
- SPAGNA
- Cataluńa
- L'HOSPITALET DE LLOBREGAT
- A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination With Doxorubicin vs. Doxorubicin Alone in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma - ES
- ICO L'Hospitalet
- Servicio de Oncología Médica (ICO L'Hospitalet)
- Ulteriori dettagli
-
- TRUSTS: A Phase IIB/III Multicenter Study Comparing the Efficacy of TRabectedin Administered as a 3-Hour or 24-Hour Infusion to Doxorubicin in Patients With Advanced or Metastatic Untreated Soft Tissue Sarcoma - ES
- Hospital Clínico San Carlos
- Servicio de Oncología Médica (H.C. San Carlos)
- Ulteriori dettagli
-
- SPAGNA
- Madrid
- MAJADAHONDA
- PICASSO III: A Phase III Multicenter, International, Randomized, Double-blind, Placebo-controlled Study of Doxorubicin Plus Palifosfamide-tris vs. Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma
- Hospital Universitario Puerta de Hierro
- Servicio de Oncología Médica (H. Puerta del Hierro)
- Ulteriori dettagli
-
- SPAGNA
- Madrid
- NOT YET IDENTIFIED - ES
- A Multinational, Randomized, Double-Blind Placebo Controlled Study of AVE8062 (25 mg/m2) Administered Every 3 Weeks in Patients With Advanced-Stage Soft Tissue Sarcoma, Treated With Cisplatin (75 mg) After Failure of Anthracycline and Ifosfamide Chemotherapies (Phase II-III)
- Not yet identified - ES
- Ulteriori dettagli
-
- SPAGNA
- Madrid
- NOT YET IDENTIFIED - ES
- PALETTE: A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy (completed)
- Not yet identified - ES
- Ulteriori dettagli
-
- SPAGNA
- Madrid
- NOT YET IDENTIFIED - ES
- A Randomized, Multicenter, Phase III Trial of Trabectedin (Yondelis) Versus Doxorubicin-based Chemotherapy as First-Line Therapy in Patients With Translocation-Related Sarcomas (TRS) - ES (Prematurely Ended)
- Not yet identified - ES
- Ulteriori dettagli
